STRIVERDI RESPIMAT (olodaterol hydrochloride) Boehringer ingelheim Patent: 7,056,916 Expiration: Dec 7, 2023 See More … For more information on how […]
Drug Patent Expirations for the Week of December 3, 2023 Read Post »
Annual Drug Patent Expirations for STIOLTO+RESPIMAT Stiolto Respimat is a drug marketed by Boehringer Ingelheim and is included in one
New patent expiration for Boehringer Ingelheim drug STIOLTO RESPIMAT Read Post »
Annual Drug Patent Expirations for STRIVERDI+RESPIMAT Striverdi Respimat is a drug marketed by Boehringer Ingelheim and is included in one
New patent expiration for Boehringer Ingelheim drug STRIVERDI RESPIMAT Read Post »
Annual Drug Patent Expirations for ZAVZPRET Zavzpret is a drug marketed by Pfizer and is included in one NDA. It
OXAYDO (oxycodone hydrochloride) Zyla Patent: 7,981,439 Expiration: Nov 26, 2023 See More … For more information on how DrugPatentWatch can
Drug Patent Expirations for the Week of November 26, 2023 Read Post »
Annual Drug Patent Expirations for OXAYDO Oxaydo is a drug marketed by Zyla and is included in one NDA. It
Annual Drug Patent Expirations for RUBRACA Rubraca is a drug marketed by Zr Pharma and is included in one NDA.
New patent expiration for Zr Pharma drug RUBRACA Read Post »
Annual Drug Patent Expirations for PROMACTA Promacta is a drug marketed by Novartis and is included in two NDAs. It
New patent expiration for Novartis drug PROMACTA Read Post »
NUCYNTA ER (tapentadol hydrochloride) Collegium pharm inc Patent: 8,309,060 Expiration: Nov 20, 2023 See More … For more information on
Drug Patent Expirations for the Week of November 19, 2023 Read Post »
Get fresh news and insights, drug patent expirations & more…
